|
Real-time Estimate
Cboe BZX
16:21:03 13/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 91.30 USD | +0.55% |
|
+10.11% | +37.73% |
| 01:02pm | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
| 08-04 | Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 93.44 | +2.91% | 25 | ||||||
| 118.42 | +6.77% | 24 | ||||||
| 98.44 | +8.46% | 25 | ||||||
| 372.58 | +18.59% | 12 | ||||||
| 30,500 | +17.26% | 15 | ||||||
| 193.25 | +5.27% | 12 | ||||||
| 44.62 | +25.68% | 26 | ||||||
| 404.73 | +14.89% | 15 | ||||||
| 3,075.38 | +18.35% | 13 | ||||||
| 263.12 | +11.21% | 8 | ||||||
| 229.79 | +27.45% | 14 | ||||||
| 107.57 | +9.89% | 21 | ||||||
| 40.3 | -4.56% | 11 | ||||||
| 93.92 | +10.12% | 13 | ||||||
| 28.73 | +6.59% | 11 | ||||||
| 208.6 | +19.87% | 15 | ||||||
| 103.23 | +20.5% | 13 | ||||||
| 171.91 | +18.51% | 22 | ||||||
| 329 | -9.14% | 5 | ||||||
| 284.95 | -1.61% | 19 | ||||||
| Average | 1,838.1 | +11.35% | 16 | ||||||
| Weighted average by Cap. | 2,480.53 | +10.81% | 19 |
- Stock Market
- Stocks
- DXCM Stock
- Sector DexCom, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
